As invading breast carcinoma cells breach their underlying basement membrane, they become confronted with a dense three-dimensional reactive stroma dominated by type I collagen. To develop metastatic capabilities, invading tumor cells must acquire the capacity to negotiate this novel microenvironment. Collagen influences the fate of epithelial cells by inducing apoptosis. However, the mechanisms used by invading tumor cells to evade collagen-induced apoptosis remain to be defined. We demonstrate that membrane type-1 matrix metalloproteinase (MT1-MMP/MMP-14) confers breast cancer cells with the ability to escape apoptosis when embedded in a collagen gel and after orthotopic implantation in vivo. In the absence of MMP-14-dependent proteolysis, type I collagen triggers apoptosis by inducing the expression of the pro-apoptotic Bcl-2-interacting killer in luminallike breast cancer cells. These findings reveal a new mechanism whereby MMP-14 activity promotes tumor progression by circumventing apoptosis.
Introduction
The interactions between cancer cells and their microenvironment represent a major aspect of tumor progression (Bissell et al., 2003; Barkan et al., 2010) . The extracellular matrix (ECM), a key component of the microenvironment, is in immediate contact with the tumor cells and functions as a critical source for growth, survival, motility and angiogenic signals that significantly affect tumor biology and progression (Hynes, 2009) . Many carcinomas and predominately breast cancers are characterized by the formation of a reactive stroma associated with extensive type I collagen (COL1) and fibrin deposition (Kauppila et al., 1998; Kalluri and Zeisberg, 2006) . A hallmark of the malignant process is the acquisition of an invasive phenotype that allows cancer cells to breach their underlying basement membrane (Hanahan and Weinberg, 2000; Liotta and Kohn, 2001) . As a consequence, carcinoma cells become confronted with the dense COL1-rich three-dimensional (3D) environment of the reactive stroma. To develop metastatic capabilities, invading tumor cells must acquire the capacity to negotiate this novel microenvironment Weinberg, 2000, 2011) .
By enmeshing cells in a dense fibrillar network, COL1 acts as a physical barrier for cell migration (Sodek et al., 2008; Sabeh et al., 2009b) . It also hinders the proliferation of both normal and cancer cells (Henriet et al., 2000; Hotary et al., 2000; Mizushima et al., 2009) , thereby acting as an endogenous antigrowth signal. However, tumor progression is governed not only by the rate of cell proliferation but also by the rate of cell attrition (Hanahan and Weinberg, 2000) . Apoptosis represents a major source of cell attrition. Aberrant cell survival resulting from an acquired resistance toward apoptosis represents a prominent hallmark of cancers Weinberg, 2000, 2011) . COL1 also influences the fate of epithelial cell populations by inducing apoptosis (Montgomery et al., 1994; Fujisaki and Hattori, 2002; Bao and Stro¨mblad, 2004) . However, the molecular mechanisms implicated in COL1-induced apoptosis remain poorly defined.
The triple-helical structure of COL1 is resistant to almost all forms of proteolytic cleavage (BirkedalHansen, 1987; Perumal et al., 2008) . To date, type I collagenolytic activity is confined to a small subset of proteinases belonging to either the cysteine proteinase or matrix metalloproteinase (MMP) families (BirkedalHansen, 1987; Nagase et al., 2006; Sabeh et al., 2009a) . MMPs are zinc-dependent endopeptidases that play crucial roles in cancer progression (Noe¨l et al., 2008; Kessenbrock et al., 2010) , not only by degrading physical ECM barriers, but also by regulating the processing of an increasing panel of molecular mediators of signaling events (Lopez-Otin and Hunter, 2010; Rodrı´guez et al., 2010) . They thus represent the most prominent family of proteinases associated with tumorigenesis (Kessenbrock et al., 2010) . There are 23 different human MMPs described to date, some of which are secreted in the pericellular environment while others are associated with the cell membrane. Membrane type-1 MMP (MT1-MMP, , the best characterized membrane-anchored MMP, is a potent matrix-degrading proteinase that digests a broad spectrum of ECM proteins, including COL1 (Ohuchi et al., 1997) , as well as a number of cell surface-associated proteins (Barbolina and Stack, 2008) . In addition to its catalytic domain, MMP-14 contains a short cytoplasmic sequence that is involved in the regulation of the enzyme activity and in the activation of signal transduction processes (Gingras and Be´liveau, 2010) . MMP-14 is overexpressed in many types of tumors, including breast carcinomas (Okada et al., 1995; Figueira et al., 2009) , where it constitutes an independent predictor of adverse outcome (McGowan and Duffy, 2008) .
To date, MMP-14 has been reported to modulate four out of the six capabilities, proposed as the 'core hallmarks of cancer', acquired by cancer cells to drive tumor progression (Hanahan and Weinberg, 2000) . In that respect, the expression of this proteinase by cancer cells is associated with self-sufficiency in growth signals (Koshikawa et al., 2011) , insensitivity to antigrowth signals (Hotary et al., 2003) , angiogenesis (Sounni et al., 2002 (Sounni et al., , 2004 , tissue invasion and metastasis (Sabeh et al., 2004) . To date, MMP-14 has not been yet implicated in either the limitless replicative potential of cancer cells or in the evasion of apoptosis.
Herein, we demonstrate that poorly invasive breast adenocarcinoma cells that do not express MMP-14 undergo apoptosis when embedded in 3D COL1 gel, a model system mimicking the microenvironment encountered by invading carcinoma cells. In contrast, the expression of MMP-14 is sufficient to confer cancer cells with the capacity to cleave the matrix and to escape apoptosis. Furthermore, we identify Bcl-2-interacting killer (BIK), a pro-apoptotic member of the Bcl-2 family, as a central mediator of COL1-induced apoptosis. Collectively, our findings unveil, for the first time, the major contribution of MMP-14 to a fifth hallmark of cancer, the evasion of apoptosis.
Results

3D COL1 induces apoptosis in poorly invasive breast cancer cells
Weakly invasive luminal-like (MCF-7 and ZR-75-1) and highly invasive basal-like (MDA-MB-231 and Hs578T) human breast cancer cell lines were embedded for up to 8 days in 3D COL1 gels and examined for morphological characteristics of apoptotic cells, including membrane blebbing, nuclear condensation and fragmentation (Galluzzi et al., 2009) . MDA-MB-231 and Hs578T cells displayed an elongated fibroblast-like morphology characterized by the presence of invasive cytoplasmic extensions ( Figure 1a) . In contrast, MCF-7 and ZR-75-1 cells remained rounded and displayed membrane blebbing, suggesting the occurrence of an apoptotic cell death. These morphological alterations were not observed when cells were incubated on two-dimensional (2D) tissue culture plastic plates (data not shown). Similar results were obtained with different preparations of COL1 including pepsin-extracted collagen ( Figure 1 ) and native acid-extracted collagens (data not shown).
To demonstrate the apoptotic nature of the observed cell death, cytoplasmic histone-associated DNA fragments were quantitated by enzyme-linked immunosorbent assay in cells recovered from 3D gels or 2D tissue culture plates. Cytoplasmic DNA fragments were strongly increased in MCF-7 and ZR-75-1 cells incubated in 3D COL1 gels (Figure 1b) . In contrast, MDA-MB-231 and Hs578T cells were insensitive to this 3D environment. The occurrence of nuclear alterations including chromatin condensation and nuclear fragmentation (Figures 1c and d) as well as the proteolytic processing of the poly (ADP-ribose) polymerase (PARP) (Figure 1e ) further confirmed the apoptotic nature of cell death observed in MCF-7 and ZR-75-1 cells. A time-course analysis performed in MCF-7 cells incubated in 3D COL1 gel revealed that DNA fragmentation increased progressively with time, reaching a maximum after 6 to 8 days ( Figure 1f ). Treatment with z-VAD-fmk, a pan-caspase inhibitor, prevented the collagen-induced apoptotic process in MCF-7 ( Figure 1g ) and ZR-75-1 (data not shown) cells. In contrast, treatment with z-DEVD-fmk, a caspase-3/-7 inhibitor, was weakly effective (data not shown).
Altogether, these results reveal that the weakly invasive luminal-like breast tumor cells growing in 3D COL1 gels underwent a z-VAD-fmk-inhibitable apoptotic process, which does not affect the highly invasive basal-like cells.
MMP-14 protects cells against COL1-induced apoptosis
To determine whether the differential sensitivity to collagen-induced apoptosis could be related to the cell capacity to remodel the matrix, we analyzed by reverse transcriptase-PCR the expression profile of five secreted (MMP-1, -2, -8, -9 and -13) and three membrane-type MMPs (MMP-14 or MT1-MMP, known to cleave COL1 (Morrison and Overall, 2006; Nagase et al., 2006; Sabeh et al., 2009a) . Most MMPs were expressed at variable levels in the different cell lines (Figure 2a ). Only MMP-14 was expressed at high levels in the two apoptosis-resistant cell lines and was completely absent in the apoptosis-sensitive cell lines, suggesting that it might be critical for that process. Mature MMP-14 (60-kDa) was detected in cell extracts of MDA-MB-231 and Hs578T cells, but not in MCF-7 and ZR-75-1 cells (Figure 2b ).
To examine a potential protective function of MMP-14 in COL1-induced apoptosis, MCF-7 cells were transiently transfected with human MMP-14 complementary DNA (Figure 2c ). MMP-14 was expressed as a 60-kDa mature form and a 43-kDa autoproteolytic degradation product, demonstrating that the enzyme was active (Lehti et al., 2000) . When incubated in 3D COL1 gels, MMP-14 expressing cells displayed a significantly reduced apoptosis (Figure 2d ). MCF-7 cells were then engineered to stably express the full-length wild-type MMP-14 (WT), a cytoplasmic domain-deleted (D-CD) mutant, a catalytically inert form (E240A) or the empty vector (CTRL). Cells transfected with the active forms of MMP-14 (WT and D-CD) expressed the 60-kDa mature form and the 43-kDa autoproteolytic degradation product (Supplementary Figure S1a) . These cells were able to activate exogenous pro-MMP-2 (Supplementary Figure S1a) and to degrade COL1 gels (Figure 3a) , revealing the presence of active MMP-14 at the cell surface. In contrast, the expression of the catalytically inert form (E240A) failed to induce MMP-2 processing (Supplementary Figure S1a) and was inefficient in degrading COL1 (Figure 3a) .
Although both wild-type and cytoplasmic domaindeleted MMP-14 exerted a protective effect toward 3D COL1-induced apoptosis, the E240A mutant was and Hs578T cells were maintained for 7 days on tissue culture 2D plastic plates or within 3D COL1 gels (Col 3D). Cells were collected and nuclear morphology was analyzed after Hoechst 33358 staining (c). Apoptotic nuclei are characterized by the presence of condensed chromatin (white arrowheads). Percentages of apoptotic nuclei observed in cells cultured on 2D plastic (white bars) or within 3D COL1 gels (black bars) were calculated (d). (e) PARP cleavage was analyzed in MCF-7 cells cultured for 7 days on 2D plastic or within 3D COL1 gels. Western blotting performed on cell lysates revealed intact (arrowhead) and cleaved (arrow) PARP. b-Actin (actin) was detected as a loading control. (f) The time course of MCF-7 cell apoptosis cultured for up to 8 days within 3D COL1 gels was analyzed by ELISA. (g) MCF-7 cells were cultured for 7 days within 3D COL1 gels in the presence or absence of increasing concentrations of a pan-caspase inhibitor (z-VAD-FMK) and apoptosis was quantified by ELISA. All data are expressed as means ± s.e.m. of at least three experiments. *Po0.05; **Po0.01.
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completely inefficient (Figure 3b ), indicating a role for the catalytic activity of the enzyme in the survival in collagen gels. Similarly, inhibiting MMP-14 activity with a synthetic inhibitor (BB-94) abolished MMP-14 autoproteolysis (Supplementary Figure S1b) , collagen degradation ( Figure 3c ) as well as the protective effect against COL1-induced apoptosis ( Figure 3d ). Although MCF-7 cells secreted undetectable levels of MMP-2, another collagenolytic MMP activated by MMP-14 (Sounni et al., 2002) , the serum-supplemented media contained significant levels of the proenzyme (Hiraoka et al., 1998) . The protective effect of the MMP-14 remained robust in MMP-2-depleted media (data not shown), suggesting that the anti-apoptotic function of MMP-14 is MMP-2-independent. We then hypothesized that MMP-14 might indirectly protect cells from apoptosis by releasing a diffusible protective factor. To test this hypothesis, apoptosis of control MCF-7 cells was evaluated in co-cultures with control or MMP-14 expressing MCF-7 cells in 3D COL1 gels. MMP-14 expressing cells failed to alleviate apoptosis in control cells (Supplementary Figure S2) , thus challenging the concept that MMP-14 might release a soluble anti-apoptotic factor.
Changes in cell survival in COL1 gels were also accompanied by marked changes in cell morphology: in the presence of active MMP-14, elongated cells with invasive cytoplasmic protrusions as well as large multicellular aggregates were observed associated with zones of extensive collagen degradation ( Figure 3e The inhibition of the catalytic activity of MMP-14 prevents collagen degradation and hinders its anti-apoptotic activity. MCF-7 cells stably expressing wild-type MMP-14 (MMP-14) or the empty vector (Control) were cultured during 7 days within 3D COL1 gels in the presence ( þ ) or absence (À) of a synthetic broad spectrum MMP inhibitor (BB-94, 1 mM). Degraded collagen (hydroxyproline) released in the medium was measured (c), apoptosis was quantified by ELISA (d) and cellular morphology was evaluated by phase contrast microscopy and hematoxylin-eosin stained sections (e). Black arrowheads indicate apoptotic cells characterized by the presence of condensed chromatin (inset); white arrowheads indicate elongated cells with invasive cytoplasmic protrusions; black arrows indicate multicellular aggregates. (f, g) Control and MMP-14 cells were embedded within 3D COL1 for up to 8 days. At indicated time points, cells were collected and apoptosis was quantified by ELISA (f) and the percentage of Ki-67-positive cells was quantified after 7 days (g). All data are expressed as means ± s.e.m. of at least three experiments. *Po0.05; **Po0.01.
anti-apoptotic influence of MMP-14 was already detectable after 4 days of culture in the 3D COL1 (Figure 3f ). The expression of MMP-14 did not significantly affect the proliferation of MCF-7 cells in the collagen gels ( Figure 3g ). We next evaluated the impact of a distinct 3D fibrillar network on tumor cell apoptosis. Fibrin, as COL1, enmeshes cancer cells in a dense, cross-linked fibrillar network in vivo that can be proteolysed by MMP-14 (Hiraoka et al., 1998; Hotary et al., 2002) . Although control cells were trapped in fibrin as multicellular, spheroid-like structures, devoid of invading cytoplasmic protrusions, MMP-14 expressing cells appeared as small cellular clusters and isolated cells with cytoplasmic protrusions invading through the gel (Supplementary Figure S3a) , suggesting that the fibrin gels are likewise sensitive to MMP-14-dependent pericellular proteolysis. Fibrin induced apoptosis to a much lower extent than collagen did. This effect was independent of MMP-14 production (Supplementary Figure S3b) . Similarly, MMP-14 did not protect MCF-7 cells against apoptosis induced by chemotherapeutic agents (including doxorubicin, etoposide and staurosporine) or tumor necrosis factor-a (Supplementary Figure S3c) .
Collectively, our results showed that the anti-apoptotic effect of MMP-14 was specific to COL1 and required the catalytic activity of the proteinase, independently of its intracytoplasmic domain.
MMP-14 prevents the upregulation of BIK by COL1 in poorly invasive breast cancer cells To further characterize the protective effect of MMP-14 on COL1-induced apoptosis, we compared, by using real-time PCR analysis, the expression of 84 different apoptosis-relevant gene transcripts in MCF-7 cells expressing or not wild-type MMP-14 incubated for 7 days in 3D COL1. Only 2 out of these 84 genes were modulated by a factor higher than twofold (Supplementary Figure S4 ). The expression of MMP-14 was associated with the downregulation of the mRNAs of two pro-apoptotic BH3-only members of the BCL-2 family, namely BIK (14-fold decrease) and Harakiri, BCL2 interacting protein (HRK: 2.6-fold decrease). The downregulation of BIK was confirmed on independent samples by semi-quantitative reverse transcriptase-PCR and by western blotting (Figure 4a) . HRK was slightly decreased by MMP-14 in these independent samples but this did not reach statistical significance (data not shown). The pro-apoptotic BH3-only proteins are key initiators of apoptosis (Lomonosova et al., 2009) . Therefore, the influence of MMP-14 on BIK expression as well as the contribution of this pro-apoptotic protein to COL1-induced apoptosis was analyzed further. The incubation of control MCF-7 cells in 3D COL1 strongly increased the expression of BIK at both the mRNA and protein levels when compared with cells maintained in 2D tissue culture plates (Figure 4a ). This induction was time-dependent, being already detectable after 24 h and reaching a maximum after 7 days in COL1 (Figure 4b ). The pan-caspase inhibitor z-VAD-fmk did not affect the induction of BIK by COL1 (data not shown), while it effectively suppressed MCF-7 cell apoptosis (see Figure 1e ). Therefore, BIK induction is not a downstream event of caspase activation. COL1 also induced the expression of BIK at both the mRNA (data not shown) and protein levels (Figure 4c and Hs578T cells were seeded on 2D plastic or within 3D COL1 gels and cultured during 8 days. BIK expression was analyzed by western blotting. b-Actin (actin) was detected as a loading control. Western blots were quantified and the intensity of BIK signal relative to actin (BIK/Act) is shown. All data are expressed as means ± s.e.m. of at least three experiments. *Po0.05; **Po0.01. Figure S3c) , it failed to modulate BIK expression (data not shown), demonstrating that the induction of BIK is not a general consequence of the activation of the apoptotic pathway. In MMP-14 expressing MCF-7 cells, the basal expression level of BIK (measured in cultures on plastic plates) was lower than in control cells (Figure 4a ), suggesting that MMP-14 regulates the expression of this pro-apoptotic gene even in the absence of COL1. Furthermore, MMP-14 completely prevented the upregulation of BIK by COL1 gels (Figure 4a) . Similar results were observed with the cytoplasmic domaindeleted MMP-14 (Figure 5a ). In contrast, the catalytically inactive mutant was unable to regulate BIK expression (Figure 5a) . Similarly, blocking the catalytic activity of wild-type MMP-14 with BB-94 restored the COL1-induced BIK upregulation (Figure 5b) .
MT1-MMP prevents collagen-induced apoptosis
We next evaluated the effect of MMP-14 on the intracellular stability of BIK mRNA. After incubating control and MMP-14 expressing MCF-7 cells in COL1 gels for 4 days, mRNA synthesis was blocked by 5,6-dichlorobenzimidazole 1-b-D-ribofuranoside (DRB), and the time-dependent decrease in the amount of BIK mRNA was quantified. This analysis demonstrated that the half-life of BIK mRNA was not affected by MMP-14 (data not shown).
Altogether, these results show that MMP-14 reduced BIK mRNA by inhibiting its transcription and that the catalytic activity of MMP-14 is essential for this process, while its cytoplasmic domain is dispensable.
BIK is required for COL1-induced apoptosis of MCF-7 cells
To test whether BIK induction is required for the COL1-induced apoptosis, we suppressed BIK expres- Figure 6 BIK is necessary for the 3D COL1-induced apoptosis in MCF-7 cells. MCF-7 cells stably expressing the empty vector were transiently transfected with a pool of small interfering RNAs (siRNAs) targeting BIK (siBIK) or a pool of siRNAs targeting SIP1 (siSIP1), used as a control. After transfection, the cells were incubated during 72 h within 3D COL1 gels. BIK expression was analyzed by western blotting (a) and apoptosis was quantified by enzyme-linked immunosorbent assay (b). b-Actin (actin) was detected as a loading control. Western blots were quantified and the intensity of BIK signal relative to actin (BIK/Act) is indicated. All data are expressed as means ± s.e.m. of at least three experiments. **Po0.01.
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sion in control MCF-7 cells by using small interfering RNAs. The transient transfection of a pool of BIKspecific small interfering RNAs strongly reduced the COL1-induced expression of BIK (Figure 6a) . A pool of small interfering RNAs targeting SIP1, a transcription factor not expressed in MCF-7 cells (Bindels et al., 2006) , was used as a control and did not affect the COL1-induced BIK expression. Cells transfected with the BIK-specific small interfering RNAs showed a marked inhibition of the COL1-induced apoptosis (Figure 6b ). Hence, BIK induction is involved in the COL1-induced apoptosis of MCF-7 cells.
The tumor-promoting effect of MMP-14 is inversely correlated with BIK expression in vivo To evaluate the influence of MMP-14 on BIK expression in vivo, control and MMP-14 expressing MCF-7 cells were injected orthotopically into the mammary fat pads of immunodeficient mice. The expression of MMP-14 by tumor cells was associated with the formation of larger tumors (Figure 7a ). The tumors derived from MMP-14 expressing cells presented a 22% lower apoptotic cell rate (Figure 7b ), similar proliferation rates ( Figure 7c ) and a reduced level of BIK mRNA transcripts when compared with control cells (Figure 7d ). 
A significant negative correlation was found between BIK mRNA levels and tumor weights (Figure 7e ), suggesting that BIK expression impaired tumor growth by increasing apoptosis.
MMP-14 and BIK expression levels are inversely regulated in breast cancer cells To further extend the negative regulation exerted by MMP-14 on BIK expression, we compared the expression patterns of these genes in a public mRNA profile data set of 50 human breast cancer cell lines (Kao et al., 2009) . MMP-14 was underexpressed in the cell lines of the well-differentiated luminal subtype of breast cancers (Supplementary Figure S5) In contrast, MMP-14 was overexpressed in the cell lines belonging to the basal subtype, which is associated with the poorest prognosis. The highest MMP-14 levels were detected in the basal-B subtype. This subtype corresponds to mesenchymal-like cell lines characterized by decreased levels of epithelial markers (such as cytokeratins and E-cadherin) and acquisition of mesenchymal proteins (including vimentin, fibronectin, slug, Twist and smooth muscle actin). This molecular profile reflects a switch toward a mesenchymal dedifferentiated phenotype, which is associated with enhanced cell motility and invasiveness (Blick et al., 2010) . The expression profile of BIK was opposite to that of MMP-14, with the lowest levels detected in the basal-B subtype and the highest levels in the luminal subtype (Supplementary Figure S5) . These observations support the widespread occurrence of an opposite regulation of MMP-14 and BIK expression in human breast cancer cells. Figures 1b and d , the highly invasive basal-like human breast cancer cell lines (MDA-MB-231 and Hs578T) were resistant to COL1-induced apoptosis. To ascertain the contribution of the MMP-dependent proteolytic activity to evasion to COL1-induced apoptosis, MDA-MB-231 and Hs578T cells were embedded in 3D COL1 gels and incubated 7 days in the presence or absence of BB-94. In agreement with previously published data (Sabeh et al., 2009b) , the inhibition of MMP activity failed to alter the phenotype of cancer cells embedded within pepsin-extracted collagen. In this setting, BB-94 did influence neither cell growth nor apoptosis (data not shown). By contrast, when MDA-MB-231 and Hs578T cells were embedded within native type I collagen (Figure 8a ), BB-94 significantly impaired their growth (63 ± 5% and 75 ± 5% of vehicle-treated cells, respectively as evaluated by measuring the DNA content of the gels). This growth reduction was not associated with an inhibition of cell proliferation (Figure 8b ) but rather with an increased rate of apoptosis (Figure 8c) . However, the apoptotic cell death induced upon BB-94 treatment was not associated with an upregulation of BIK, which was minimally expressed at the mRNA level and undetectable at the protein level (data not shown).
Inhibition of MMPs restores COL1-induced apoptosis in highly invasive breast cancer cells As illustrated in
We then examined whether the forced expression of BIK in these cells was sufficient to induce apoptosis. MDA-MB-231 and Hs578T cells were transiently transfected with human BIK complementary DNA (an empty vector and enhanced green fluorescent protein (EGFP) complementary DNA were used as controls). At 48 h after transfection, BIK was detected in the lysates of both cell lines, however, at a much lower level in MDA-MB-231 cells (Supplementary Figure S6a) , because of the low transfection efficiency of these cells as assessed by the expression of EGFP (data not shown). The transient expression of BIK increased apoptosis in both cell lines (Supplementary Figure S6b) to a level proportional to the extent of BIK expression.
Taken together, these results show that the inhibition of MMP activity in highly invasive basal-like breast cell lines induced a BIK-independent apoptotic program when cultured within native type I collagen. However, despite their inability to upregulate BIK expression, these cells remain sensitive to the pro-apoptotic function of this protein.
Discussion
To develop metastatic features, tumor cells must evolve the capacity to survive in novel microenvironments Weinberg, 2000, 2011) . In breast cancer, invasive tumor cells breach their underlying basement membrane and come in direct contact with the surrounding activated collagenous stroma. To elucidate the impact of this collagenous microenvironment on breast cancer progression, we used a 3D COL1 matrix that closely recapitulates the tissue architecture observed in vivo (Yamada and Cukierman, 2007) . Our results reveal that 3D COL1 is able to restrain cancer cell expansion by selectively inducing apoptosis in weakly invasive luminal-like breast carcinoma cell lines that retain epithelial characteristics (that is, MCF-7 and ZR-75-1 cells). By contrast, highly invasive basal-like breast carcinoma cells that assume a mesenchymal-like phenotype (MDA-MB-231 and Hs578T) are resistant to 3D COL1-induced apoptosis (Figure 1) . We provide evidence that MMP-14 is sufficient to endow weakly invasive breast carcinoma cells with the capability to circumvent apoptosis imposed by the ECM and to promote the invasion of the collagen (Figures 2 and 3) . Our results thus show that by mitigating 3D COL1-induced apoptosis, MMP-14 is conferring a survival advantage to breast cancer cells.
BIK, a pro-apoptotic tumor suppressor, which belongs to the BH3-only members of the Bcl-2 family (Chinnadurai et al., 2008) , was specifically downregulated in MMP-14 expressing MCF-7 cells (Figure 4) . The BH3-only proteins are the major sentinels for cellular stress, and diverse signaling pathways converge on these proteins (Giam et al., 2008) . BIK operates with other BH3-only proteins to cause rapid activation of caspases (Giam et al., 2008) . The expression of BIK is induced by diverse treatments including doxorubicin, g-irradiation or overexpression of p53 (Hur et al., 2004; Mathai et al., 2005; Chinnadurai et al., 2008) and is sufficient to induce apoptosis in cancer cells (Zou et al., 2002; Naumann et al., 2003) . We demonstrate that apoptosis induced by 3D COL1 is associated with a robust accumulation of BIK in the COL1-sensitive basal-like breast carcinoma cell lines (Figure 4) . Furthermore, by specifically silencing BIK protein accumulation, we provide evidence that the COL1-induced apoptosis of MCF-7 cells is largely dependent on BIK overexpression (Figure 6 ). The stability of the BIK mRNA transcripts in COL1-embedded MCF-7 cells is not affected by MMP-14, suggesting that this proteinase is regulating BIK expression at a transcriptional level.
MMP-14 is tethered to the cell surface by a transmembrane segment that terminates in a short cytoplasmic domain (Sato et al., 2005) . The extracellular proteinase portion containing the zinc-containing catalytic domain endows this enzyme with the unique ability to modify the surrounding microenvironment by proteolysis as well as to interact with the intracellular transduction machinery involved in the cellular response to extracellular signals (Gingras and Be´liveau, 2010) . Despite reports documenting important roles for the MMP-14 cytoplasmic domain in regulating MMP-14 endocytosis, recycling and activation of signal transduction events (Gingras and Be´liveau, 2010) , we find, however, that cytoplasmic domain-deleted (D-CD) MMP-14 is able to prevent the collagen-induced accumulation of BIK and apoptosis as efficiently as the wild-type enzyme (Figures 3a and 5) , thus ruling out a direct contribution of the cytoplasmic domain in these processes. In agreement with our findings, the cytoplasmic domain-deleted MMP-14 remains competent to promote the invasion of cancer cells through a basement membrane (Hotary et al., 2006) . In contrast, inhibiting the catalytic activity of MMP-14 with a broad-spectrum synthetic inhibitor (BB-94) or by a point mutation in the MT1-MMP prevents collagen-induced apoptosis E Maquoi et al catalytic domain (E240A mutant) abrogates collagenolysis, promotes BIK expression and suppresses the protection against COL1-induced apoptosis ( Figures  3a and 5 ). These observations are consistent with a requirement for the cleavage of specific(s) substrate(s) by MMP-14.
Many of the MMP-14 activities have been ascribed to its ability to bind and activate the MMP-2 zymogen (Sato et al., 2005) . However, the protective function of MMP-14 against COL1-induced apoptosis demonstrated here is conserved in the absence of MMP-2, arguing for a direct implication of MMP-14 in this process. MMP-14 can directly cleave different ECM substrates, including COL1 and fibrin (Ohuchi et al., 1997; Hiraoka et al., 1998; Hotary et al., 2000) . It can be speculated that intact COL1 might signal through cell surface receptors, thereby inducing the expression of BIK. By cleaving COL1, MMP-14 might suppress this pro-apoptotic signal. Alternatively, the cleavage of COL1 by MMP-14 might expose a cryptic survival factor that prevents apoptosis on binding to cell surface receptors (Montgomery et al., 1994) . Besides its wellrecognized capacity to cleave structural ECM molecules, MMP-14 also induces the release, activation or inactivation of autocrine/paracrine signaling molecules as well as cell surface receptors (including a v b 3 integrin, CD44) that transduce signals from the extracellular environment (Sternlicht and Werb, 2001; Egeblad and Werb, 2002; Butler et al., 2008) . Consequently, MMP-14 might influence the transcription of BIK through modulations of the intracellular transduction machinery. Further studies are required to determine the exact mechanism(s) by which the catalytic activity of MMP-14 prevents the COL1-mediated upregulation of BIK expression.
Several different subtypes of breast carcinomas can be identified based on gene expression profiling studies (Sorlie et al., 2001) . Although the luminal subtype is characterized by its mild invasive capacity and relatively good clinical outcome, the basal-like subtype is characterized by enhanced invasiveness and formation of distant metastasis and, thereby, a poor clinical outcome (Sorlie et al., 2001; Rouzier et al., 2005) . The enhanced metastatic capacity of basal-like breast cancer cells is associated with their migratory, mesenchymal-like phenotype (Sarrio´et al., 2008) . The acquisition of such an invasive phenotype requires the induction of an epithelial-to-mesenchymal cell transition (EMT), which triggers epithelial cell-derived cancer cells to adopt a tissue-invasive, mesenchymal cell-like phenotype (Polyak and Weinberg, 2009 ). MMP-14 represents a known constituent of the EMT molecular signature (Kao et al., 2009; Blick et al., 2010) specifically enriched in the basal-like subtype. Forced expression of MMP-14 in luminal-like breast cancer cells is sufficient to partially phenocopy the EMT-mediated invasive program (Ota et al., 2009) . Consistent with the observation that BIK is underexpressed in the EMT-prone basal-like cell lines (Supplementary Figure S5) , recent data reveal that the induction of EMT in human mammary epithelial cells by different EMT regulators is associated with a constant downregulation of BIK (Taube et al., 2010) .
Thus, BIK may represent a critical epithelial feature that has to be turned off to allow invasive cancer cells to survive in the collagen-rich tumor stroma. The inhibition of MMP activity in MDA-MB-231 and Hs578T cell lines cultured within native COL1 induced apoptosis (Figure 8 ), highlighting that this novel anti-apoptotic effect can be extended to different breast cancer cell lines. However, the lack of BIK expression by these cells suggests the activation of alternative apoptotic pathways that compensate for BIK deficiency. Despite their failure to express BIK, the forced expression of this gene in the basal-like breast cell lines was sufficient to induce apoptosis (Supplementary Figure S6) , suggesting that these cells remain sensitive to BIK-mediated apoptotic cell death. The reason why these cells fail to express BIK upon MMP inhibition remains unclear. However, BIK is repressed in a number of malignant cell lines because of hypermethylation (Kim et al., 2006; Sturm et al., 2006) .
Collectively, the results presented here show that in the absence of MMP-dependent proteolytic activity, COL1 induces apoptosis in both basal-and luminal-like breast carcinoma cells. In these latter cells, apoptosis is mediated through the upregulation of BIK. In contrast, this pro-apoptotic gene is dispensable for apoptosis in basal-like cells. Evasion to COL1-induced apoptosis represents an important survival mechanism for carcinoma cells confronted with a dense collagen-rich environment, thereby promoting their dissemination through the reactive stroma. Our findings reveal that in addition to its previously recognized roles in four out of the six hallmarks of cancer, that is, self-sufficiency in growth signals, insensitivity to anti-growth signals, tissue invasion and metastasis and sustained angiogenesis, MMP-14 is also orchestrating tumor progression by enabling cancer cells to evade apoptosis, another hallmark of cancer.
Materials and methods
Cell lines and reagents MCF-7, MDA-MB-231, Hs578T and ZR-75-1 cells were obtained from the American Type Culture Collection (Rockville, MD, USA). z-VAD-fmk (halomethyl ketone benzyloxycarbonyl-VAD fluoromethyl ketone) was from Bachem (Bubendorf, Switzerland) and z-DEVD-fmk was from R&D Systems (Abingdon, UK). Doxorubicin, etoposide, staurosporine and tumor necrosis factor-a were from Sigma (Bornem, Belgium). The broad-spectrum hydroxamic acid-based synthetic MMP inhibitor BB-94 (Eccles et al., 1996) was used at a final concentration of 1 mM in 0.1% dimethylsulphoxide. Gelatinase-depleted serum was obtained after incubation of fetal calf serum with gelatine-sepharose 4B beads (Pharmacia Biotech, Uppsala, Sweden).
Cell culture, expression vectors and transfection All cells were maintained in Dulbecco's modified Eagle's medium supplemented with 10% (v/v) fetal calf serum, 100 IU/ ml penicillin, 100 mg/ml streptomycin and 2 mM glutamine at 37 1C in a humid atmosphere (5% CO 2 and 95% air). All culture reagents were purchased from Invitrogen (Merelbeke, Belgium). The human full-length BIK complementary DNA was purchased from Origene Technologies (Rockville, MD, USA) and the pEGFP plasmid was from Clontech (Mountain View, CA, USA). Expression vectors (pcDNA3.1/Zeo, Invitrogen) with full-length wild-type human MMP-14, cytoplasmic domain-deleted (D-CD) and catalytically inactive (E240A) mutants were described previously (Sounni et al., 2004) . MCF-7 cells were transiently transfected with the full-length MMP-14 expression vector using Fugene transfection reagent (Roche, Mannheim, Germany). Stable transfectants were obtained by electroporation using a gene pulser system (BioRad, Richmond, CA, USA). See Supplementary materials for details and other methods used.
Quantification of apoptosis
Cells recovered from 3D gels or detached from tissue culture plastic plates were lysed and cytoplasmic histone-associated DNA fragments were quantitated by enzyme-linked immunosorbent assay (Cell Death Detection ELISA PLUS , Roche) according to the manufacturer's instructions. A relative apoptotic ratio was then obtained by normalizing the enzyme-linked immunosorbent assay absorbance with the total DNA content. DNA was quantitated by fluorimetry with the Hoechst 33258 dye. Apoptosis was also quantitated by evaluating the percentages of cells with chromatin condensation and nuclear fragmentation. Cells suspensions were fixed with chilled methanol and incubated with 5 mg/ml Hoechst 33258. At least 250 cells were examined to quantify apoptosis.
In vivo tumorigenic assay Cell suspensions prepared in serum-free medium were injected into the mammary fat pads (3 Â 10 6 cells per fat pad) of 6-8 weeks old female athymic nude BALB/c nu/nu mice (Iffa Credo, Les Onci, France) previously implanted with 60 dayrelease estradiol pellets (Innovative Research of America, Sarasota, FL, USA). Mice were killed after 60 days and the tumors were collected and their weights were measured. Apoptotic cells were identified by TUNEL staining of formalin-fixed and paraffin-embedded sections of tumor samples using TumorTACS in situ Apoptosis Detection Kit (Trevigen, Gaithersburg, MD, USA), according to the manufacturer's instructions. Proliferating cells were identified by immunolabelling with the mouse monoclonal anti-proliferating cell nuclear antigen antibody (Dako, Heverlee, Belgium). The number of TUNEL-and proliferating cell nuclear antigenpositive cells per microscopic field ( Â 20 magnification) was determined. Inflammatory sites were excluded.
Statistical analysis
All quantitations experiment data are expressed as mean± s.e.m. Statistical analysis were conducted with GraphPad Prism software (La Jolla, CA, USA) using one-way analysis of variance followed by Boneferroni's test or using KruskalWallis followed by Dunn's test. Po0.05 was considered statistically significant.
